BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16959589)

  • 1. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
    Lakhani K; Prelevic GM; Seifalian AM; Atiomo WU; Hardiman P
    J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S; Guzick D
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
    Talbott EO; Zborowskii JV; Boudraux MY
    Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome.
    Lambrinoudaki I
    Maturitas; 2011 Jan; 68(1):13-6. PubMed ID: 20943333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
    Bhathena RK
    J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in polycystic ovary syndrome.
    Prelevic GM
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome.
    Ehrmann DA
    N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR; Healy DL
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.
    Bekx MT; Connor EC; Allen DB
    J Pediatr Adolesc Gynecol; 2010 Feb; 23(1):7-10. PubMed ID: 19648034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term health consequences of polycystic ovaries syndrome: metabolic, cardiovascular and oncological aspects].
    Gutman G; Geva E; Lessing JB; Amster R
    Harefuah; 2007 Nov; 146(11):889-93, 908. PubMed ID: 18087838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and cardiovascular disease.
    Loverro G
    Minerva Endocrinol; 2004 Sep; 29(3):129-38. PubMed ID: 15282445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.